PharmaCann Inc. plans to close its massive Denver cannabis grow facility in two months, wiping out 132 jobs in a stark sign of Colorado’s weed market woes. The move ends the Chicago company’s short stint in the state and spotlights brutal industry pressures like crashing prices and too much supply. Workers face tough times ahead as consolidation grips the sector.
PharmaCann filed a WARN notice with Colorado labor officials on March 20. The company will shut the entire 190,000-square-foot plant at 5141 N. National Western Drive on May 20, 2026. Chief manufacturing officer Nathan Fete made the announcement clear.
No union protects the workers. No bumping rights exist for them to shift to other jobs. The layoffs come permanent with no plans to reopen.
This plant ranked among Colorado’s biggest. Public records peg its 2024 taxable value at $6 million. It handled cultivation and processing for adult-use cannabis.
Colorado Weed Market in Freefall
Wholesale flower prices tell the story. They peaked at $1,721 per pound in 2021. By December 2025, they plunged to $648 per pound, per BusinessDen data.
Retail sales keep sliding too. Colorado dispensaries rang up just over $1.3 billion in 2025, down more than 6% from 2024. Units sold dropped 7.3% year over year, from 91.6 million to 84.9 million.
Grower licenses shrank fast. The Marijuana Enforcement Division counted 817 adult-use cultivators in mid-2022. Now about 488 remain as of late 2025.
| Year/Month | Licensed Adult-Use Cultivators |
|---|---|
| Mid-2022 | 817 |
| Dec 2025 | 488 |
Oversupply fuels the pain. New states legalize weed. Competition heats up. Big players snap up smaller ones.
PharmaCann Bought High, Now Bails
PharmaCann jumped into Colorado in February 2022. It grabbed LivWell Enlightened Health in an all-stock deal. Later added The Clinic dispensaries.
Trouble brewed quick. The firm missed lease payments. It settled with its top landlord.
In December 2025, PharmaCann sold key assets to Vireo Growth Inc. The deal hit $49 million in stock. It covered 17 LivWell stores, inventory, contracts, and IP.
Vireo eyes an asset-light path. It buys flower on the open market. No need for extra grows like this one. Vireo plans to close the retail spots by mid-2026.
PharmaCann stays strong elsewhere. Founded in 2014, the firm runs vertically integrated ops in New York, Illinois, Maryland, and Pennsylvania. It focuses on safe, top-shelf products.
One expert nails it. PharmaCann bought at the market top and now pays the price by pulling out of Colorado.
Workers and Future Shakeout
The 132 layoffs sting families in North Denver. Many built careers in the green rush. Now they hunt new gigs amid a cooling boom.
State data shows consolidation ramps up. Vireo grabbed Schwazze via a $111 million credit bid. That added grows and stores. It also bought Eaze assets for $47 million in stock after Eaze axed 45 jobs at another Denver plant.
Vireo now runs about 55 dispensaries. It claims the top retailer spot in Colorado.
Lower prices help buyers. A pound of retail marijuana dipped below $600 this spring, the lowest since tracking started in 2014. But growers suffer.
Tax cash dips too. Marijuana revenue hit $231.1 million in fiscal 2024-25. That’s 45.5% off the 2020-21 peak.
This closure warns of more pain. Smaller ops fold. Survivors get leaner. Jobs shift to retail or other states.
Colorado’s cannabis dream turns gritty reality. Early pioneers cashed in big. Now mid-tier players like PharmaCann exit stage left. The 132 workers left jobless embody the human cost of a market devouring its own.
Vireo bets on scale to win. It snagged Hawthorne Gardening supplies from Scotts Miracle-Gro for cheap inputs. Smart moves in a dogfight.
Consumers see deals. But the thrill fades as black market lingers and new rivals pop up.
As Colorado’s weed world reshapes, loyal fans wonder what’s next. Will prices bottom out more? Can jobs rebound? This shakeout clears weak hands for stronger growth down the road. It hurts now, but a healthier industry may emerge.
Maria Garcia is an award-winning author who excels in creating engaging cannabis-centric articles that captivate audiences. Her versatile writing style allows her to cover a wide range of topics within the cannabis space, from advocacy and social justice to product reviews and lifestyle features. Maria’s dedication to promoting education and awareness about cannabis shines through in her thoughtfully curated content that resonates with both seasoned enthusiasts and newcomers alike.
